New potent HBV replication inhibitors for the management of chronic hepatitis B are needed.

Saved in:
Bibliographic Details
Title: New potent HBV replication inhibitors for the management of chronic hepatitis B are needed.
Authors: Block TM; Baruch S. Blumberg Institute, Doylestown, PA, USA. tim.block@bblumberg.org., Guo JT; Baruch S. Blumberg Institute, Doylestown, PA, USA., Zoulim F; Viral Hepatitis Research Laboratory of INSERM Unit 1052, Hepatology Department, Hospices Civils de Lyon, University of Lyon, Lyon, France., Rice CM; Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA., Thio CL; Department of Medicine, Johns Hopkins University, Baltimore, MD, USA., Schneider WM; Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA., Alter HJ; Department of Transfusion Medicine Clinical Center, The National Institutes of Health Bethesda, Bethesda, MD, USA., Jacobson IM; Department of Medicine, NYU Langone Health, New York, NY, USA., Gish RG; Hepatitis B Foundation, Doylestown, PA, USA., Block PD; Division of Gastroenterology and Hepatology, New York University Langone Hospital, New York, NY, USA., Sulkowski M; Department of Medicine, Johns Hopkins University, Baltimore, MD, USA., Feld JJ; Toronto Centre for Liver Disease, University Health Network, Toronto, Ontario, Canada., Cohen CA; Hepatitis B Foundation, Doylestown, PA, USA.
Source: Nature reviews. Gastroenterology & hepatology [Nat Rev Gastroenterol Hepatol] 2025 Mar; Vol. 22 (3), pp. 150-151.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500079 Publication Model: Print Cited Medium: Internet ISSN: 1759-5053 (Electronic) Linking ISSN: 17595045 NLM ISO Abbreviation: Nat Rev Gastroenterol Hepatol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1759-5053
DOI:10.1038/s41575-025-01037-z